Results 171 to 180 of about 125,630 (346)
The cost‐effectiveness of intraoperative margin assessment strategies during radical prostatectomy
Objective To determine whether current intraoperative margin assessment (IOMA) techniques (such as Neurovascular Structure Adjacent Frozen‐section Examination [NeuroSAFE] or confocal laser microscopy [CLM]) used during radical prostatectomy (RP) to enhance nerve‐sparing surgery (NSS) while reducing positive surgical margins (PSMs) justify their extra ...
Joost van Drumpt +7 more
wiley +1 more source
Urinary bladder spindle-cell neoplasm concomitant with urothelial cancer
Jeng-Sheng Chen +6 more
openalex +1 more source
This multicenter prospective study examined the impact of urinary diversion on HRQOL among bladder cancer patients who underwent radical cystectomy. Evaluation using the BCI clarified changes in HRQOL related to urinary, bowel, and sexual domains before surgery and at 3, 6, and 12 months postoperatively.
Shuhei Yamada +32 more
wiley +1 more source
Clinicohistopathological Correlation and Prognostic Significance of Molecular Biomarkers in Urinary Bladder Neoplasms: A Comprehensive Analysis. [PDF]
Mane A, Patil NJ, Hulwan AB, Koley A.
europepmc +1 more source
Urinary tumor DNA (utDNA) represents a powerful noninvasive biomarker to refine the need for repeat TURBT in high‐risk NMIBC. In our cohort of 161 patients, utDNA testing achieved superior accuracy to cytology, strongly predicted residual disease and recurrence, and could safely reduce unnecessary repeat resections by up to one‐third.
Zihan Xue +8 more
wiley +1 more source
Impact of Implementing Paris System on Diagnostic Precision and Management of Urinary Bladder Neoplasms. [PDF]
Arora S +5 more
europepmc +1 more source
Perspectives For Target Therapy In The Treatment Of Malignant Neoplasms Of The Urinary Bladder
Olga Antonova +4 more
openalex +2 more sources
In this study, we investigated the predictive value of tumor mutational burden (TMB) for assessing the efficacy of pembrolizumab in a Japanese cohort. We analyzed real‐world data from 63,952 patients registered in the C‐CAT database who underwent comprehensive genomic profiling, and evaluated the therapeutic efficacy of pembrolizumab in 1899 of these ...
Tomoyo Yasuda +7 more
wiley +1 more source
THE TECHNIC OF THE OPERATIVE TREATMENT OF NEOPLASMS OF THE URINARY BLADDER
Edwin Beer
openalex +2 more sources

